Tony Vahedian, CEO at CCSA report from the Peterson Health Technology Institute (PHTI) found that many digital diabetes management platforms aren’t providing meaningful ROI for patients or the health system as a whole.  Users of common technologies only see small, incremental clinical benefits, such as 0.23%–0.60% point reduction in HbA1c when compared to traditional care. Meanwhile, some health plans and employers are actually seeing an increase in overall costs as spending on these platforms can often exceed savings from improved clinical outcomes.This is not news that anyone wanted to hear, especially in light of the enormous health plan investment in digital health platforms during the COVID-19 pandemic. We have learned some incredible lessons from implementing and adapting digital health solutions quickly during the pandemic and can use these learnings to drive additional innovation in our new normal.Why the disappointing disconnect? Because timing is everything when trying to change the status quo, and the pandemic hit at a critical juncture in the maturity curve of the digital health environment. While many of these platforms were on the right track to use virtual innovations for reducing the fragmentation and frustration of the face-to-face patient experience, the sudden urgency to shift everything fully online to meet basic care needs forced some of these issues to the back burner. As a result, some platforms are finding it difficult to loop back and address the gaps that have been unintentionally baked into their current models.Now that the urgency of the COVID era has lessened, however, it’s time to regroup. Digital health innovators — and the providers and health plans they serve — should take this moment to reflect on solving the fundamental pain points of the patient experience, regardless of the channel, and then decide how to strategically apply digital tools to further improve the organic, fundamental relationships upon which all of healthcare is built.Think in terms of relationshipsHealthcare has built-in buy-in from consumers, but some people still think it’s not their “job” to take a leadership role in their health and well-being — it’s the job to be done by their provider and health plan. Worse yet, far too many healthcare stakeholders fail to realize that having this “captive” consumer audience doesn’t automatically mean they are engaged, educated, and empowered to own and lead their health journey. Digital health innovators cannot assume that checking off a to-do task in an app is an indicator of optimal adherence or that ordering medications and/or supplies regularly means the consumer completely understands how to use them to manage their health. When digital care platforms rely too heavily on this transactional approach as a proxy for engagement, they lose the essence of what it means to live with a chronic condition

CCS Unveils PropheSee: AI Predictive Model Predicts and Improves CGM Adherence in Diabetes Management. by Syed Hamza Sohail 06/11/2024 Leave a Comment. What You Should Know:–              CCS — leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — today announced PropheSee™ a new, AI-powered predictive model for healthcare organizations focused on improving adherence in the population of people that have been prescribed a continuous glucose monitoring (CGM) device to help manage their diabetes.–              In addition to improved clinical outcomes, health plans and risk-bearing providers can also realize savings of up to $2,200 per patient per year from this increase in CGM adherence.PropheSee Model Boosts Adherence Rates in High-Risk Patient Cohorts by 50%CCS has observed a remarkable 50% increase in adherence rates among high-risk patient cohorts following the deployment of its new predictive model, PropheSee. This significant improvement is attributed to tech-enabled, personalized interventions based on risk classification, combined with the timely delivery of patient-specific information and insights that support long-term therapy adherence.CCS leverages a comprehensive dataset that includes decades of proprietary patient behavior data, offering a far more holistic view of an individual’s health and well-being compared to traditional claims data, which is often delayed and incomplete. Additionally, the integration of patient-level Social Determinants of Health (SDOH) data provides a more complete understanding of each patient. This enables healthcare organizations to proactively identify those most at risk of discontinuing therapy.As a leading chronic care management company, CCS provides clinical solutions and home-delivered medical supplies for individuals with chronic conditions, particularly diabetes

DALLAS--(BUSINESS WIRE)--CCS — leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — today announced a new report revealing 57% of individuals living with diabetes in the United States think GLP-1 weight loss drugs alone may be a silver bullet for helping achieve their health goals. CCS, in collaboration with independent market research firm PureSpectrum, surveyed more than 1,500 individuals living with diabetes to understand their attitude as it relates to an array of timely issues, including growing demand for GLP-1 weight loss drugs and whether people living with type 2 diabetes feel like their provider relationship is setting them up for success when it comes to self-management of their chronic disease. “GLP-1 weight loss drugs alone are not a silver bullet when it comes to improving the health and well-being of those living with diabetes,” said Dr. Arti Masturzo, Chief Medical Officer at CCS. “These drugs do offer hope for those living with diabetes and others looking to manage obesity, but they should be prescribed in conjunction with hands-on personalized education and coaching, as well as the appropriate medical device technology needed to streamline diabetes self-management.”. Beyond GLP-1 weight loss drugs, a broad lack of focus on patient education and coaching for people living with diabetes was also highlighted in this report